JP2015214494A5 - - Google Patents

Download PDF

Info

Publication number
JP2015214494A5
JP2015214494A5 JP2014096390A JP2014096390A JP2015214494A5 JP 2015214494 A5 JP2015214494 A5 JP 2015214494A5 JP 2014096390 A JP2014096390 A JP 2014096390A JP 2014096390 A JP2014096390 A JP 2014096390A JP 2015214494 A5 JP2015214494 A5 JP 2015214494A5
Authority
JP
Japan
Prior art keywords
acid
composition
transdermal administration
administration according
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014096390A
Other languages
English (en)
Japanese (ja)
Other versions
JP6346491B2 (ja
JP2015214494A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014096390A priority Critical patent/JP6346491B2/ja
Priority claimed from JP2014096390A external-priority patent/JP6346491B2/ja
Publication of JP2015214494A publication Critical patent/JP2015214494A/ja
Publication of JP2015214494A5 publication Critical patent/JP2015214494A5/ja
Application granted granted Critical
Publication of JP6346491B2 publication Critical patent/JP6346491B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014096390A 2014-05-07 2014-05-07 経皮投与用組成物 Active JP6346491B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014096390A JP6346491B2 (ja) 2014-05-07 2014-05-07 経皮投与用組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014096390A JP6346491B2 (ja) 2014-05-07 2014-05-07 経皮投与用組成物

Publications (3)

Publication Number Publication Date
JP2015214494A JP2015214494A (ja) 2015-12-03
JP2015214494A5 true JP2015214494A5 (enExample) 2017-03-30
JP6346491B2 JP6346491B2 (ja) 2018-06-20

Family

ID=54751747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014096390A Active JP6346491B2 (ja) 2014-05-07 2014-05-07 経皮投与用組成物

Country Status (1)

Country Link
JP (1) JP6346491B2 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5236867B2 (ja) * 2006-03-16 2013-07-17 株式会社コーセー 固形化粧料
JP2012041276A (ja) * 2010-08-12 2012-03-01 Maruzen Pharmaceut Co Ltd タンパク質のカルボニル化抑制剤及び肌の透明感向上剤
JP2012041318A (ja) * 2010-08-23 2012-03-01 Mikimoto Pharmaceut Co Ltd シワ形成抑制用基剤
JP5921187B2 (ja) * 2011-12-28 2016-05-24 花王株式会社 皮膚外用剤

Similar Documents

Publication Publication Date Title
IL275578A (en) Fatty acid conjugates of cysteamine and their uses as activators of autophagy
IL274742A (en) Pharmaceutical preparations containing the compound dextromethorphan and quinidine for the treatment of restlessness in dementia
JP2014122196A5 (enExample)
EP4371616A3 (en) Compositions of obeticholic acid and methods of use
EP3174874A4 (en) BERBERINSALZE, URSODEOXYCHOLSALZE AND COMBINATIONS, METHOD FOR THE PRODUCTION AND THE APPLICATION THEREOF
EP3022310A4 (en) Microorganisms and methods for the production of fatty acids and fatty acid derived products
MX2016004487A (es) Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.
EP3661600A4 (en) FATTY ACID ANALOGS AND ITS USE IN THE TREATMENT OF DISEASES RELATED TO METABOLISM SYNDROME
EP3102186A4 (en) Donepezil compositions and method of treating alzheimer's disease
EP3151923A4 (en) Clear compositions and methods for the delivery of active ingredients for skin care
PL3319620T3 (pl) Bakteria lactobacillus paracasei do produkcji sprzężonego kwasu linolowego, zawierające ją preparaty odżywcze i farmaceutyczne oraz ich zastosowania
EP3613833C0 (en) LONG-CHAIN MONOUNSATURATED FATTY ACID COMPOSITION AND LONG-CHAIN POLYUNSATURATED FATTY ACID COMPOSITION AND PROCESS FOR PRODUCING THE SAME
SG11201608217PA (en) Fatty acid composition and use thereof
ZA201703833B (en) Oral care products and methods of use and manufacture thereof
MA52644A (fr) Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation
TN2015000498A1 (en) Modified release formulation
SG11201803022TA (en) Compositions comprising fatty acids and their use
HUE042932T2 (hu) Koleszterinészter-transzferprotein (CETP) inhibitor és az említett inhibitort tartalmazó gyógyászati készítmény szív- és érrendszeri betegségek kezelésében vagy megelõzésében való alkalmazásra
JP2015214494A5 (enExample)
GB201602574D0 (en) Process for the chemical modification of Alkanes, Fatty Acids and Fatty Alcohols
WO2016081671A8 (en) Pharmaceutical matrix formulations comprising dimethyl fumarate
ZA201607492B (en) Preparation of zinc citrate and of zinc citrate-containing oral care compositions
JP2016086757A5 (enExample)
PL3085383T3 (pl) Kompozycja farmaceutyczna zawierająca erytropoietynę i ceftriakson oraz jej wykorzystanie w wytwarzania leku do leczenia choroby parkinsona
BR112017005618A2 (pt) ?sal de éster metílico de fenilglicina?.